Entera Bio
ENTX
9 hedge funds and large institutions have $3.28M invested in Entera Bio in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
4,400% more call options, than puts
Call options by funds: $45K | Put options by funds: $1K
690% more capital invested
Capital invested by funds: $416K → $3.28M (+$2.87M)
0.76% less ownership
Funds ownership: 10.59% → 9.83% (-0.76%)
25% less funds holding
Funds holding: 12 → 9 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$129K |
| 2 |
Millennium Management
New York
|
-$34K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$30.4K |
| 4 |
HF
HRT Financial
New York
|
-$11K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$647 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $2.88M | – | – | – |
|
|
RCM
2
RA Capital Management
Boston,
Massachusetts
| $343K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $20.4K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $12K | -$129K | -129,200 | -93% |
|
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $11.6K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $11.3K | -$647 | -648 | -6% |
|
|
7
JP Morgan Chase
New York
| $2K | +$1.87K | +1,868 | New |
|
8
Morgan Stanley
New York
| $1.16K | – | – | – |
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
10
Millennium Management
New York
| – | -$34K | -46,000 | Closed |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$30.4K | -30,465 | Closed |
|
|
HF
12
HRT Financial
New York
| – | -$11K | -15,236 | Closed |
|
13
BlackRock
New York
| – | -$365 | -500 | Closed |
|
ENTX Hedge Fund Activity: Q1 2023 in Review
9 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q1 2023, worth a combined $3.28M — up 690% from $416K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ENTX and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $1.87K. The largest seller was Renaissance Technologies, cutting an estimated $129K.
- 9 institutional investors held Entera Bio (ENTX) as of Q1 2023, down from 12 in Q4 2022.
- Funds reported $3.28M of Entera Bio stock for Q1 2023, up 690% quarter-over-quarter.
- 1 fund opened new Entera Bio positions in Q1 2023 and 4 closed out, a net change of -3 holders.
- The largest Entera Bio buyer in Q1 2023 was JP Morgan Chase, an estimated $1.87K added.
- The largest Entera Bio seller in Q1 2023 was Renaissance Technologies, an estimated $129K sold.
Based on aggregated 13F filings for Q1 2023.